Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Infectious Diseases

• Publication date

  2012-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/infdis/jis383PMID 22693226PMCID PMC3491749
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Harnessing the biology of IL-7 for therapeutic application

  2011cited by this paper
• Emerging opportunistic yeast infections.

  2011cited by this paper
• IL-17 signaling in host defense against Candida albicans

  2011cited by this paper
• Fungal sepsis: optimizing antifungal therapy in the critical care setting.

  2011cited by this paper
• IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology.

  2011cited by this paper
• Interleukin-7 (IL-7) Treatment Accelerates Neutrophil Recruitment through γδ T-Cell IL-17 Production in a Murine Model of Sepsis

  2010cited by this paper
• Epidemiology of invasive candidiasis

  2010cited by this paper
• Invasive fungal infections in congenital immunodeficiencies.

  2010cited by this paper
• Chronic mucocutaneous candidiasis and congenital susceptibility to Candida

  2010cited by this paper
• Immunomodulatory cell therapy in sepsis: have we learnt lessons from the past?

  2010cited by this paper
• A case of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia.

  2010cited by this paper
• Impairment of Host Defense against Disseminated Candidiasis in Mice Overexpressing GATA-3

  2010cited by this paper
• IL-7 Promotes T Cell Viability, Trafficking, and Functionality and Improves Survival in Sepsis

  2010influential reference
• DIFFERENTIAL IMMUNOLOGICAL PHENOTYPES ARE EXHIBITED AFTER SCALD AND FLAME BURNS

  2009cited by this paper
• The sepsis seesaw: tilting toward immunosuppression

  2009influential reference
• Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment.

  2009cited by this paper
• Modulating T‐cell homeostasis with IL‐7: preclinical and clinical studies

  2009cited by this paper
• IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.

  2009cited by this paper
• Differential lymphopenia‐induced homeostatic proliferation for CD4+ and CD8+ T cells following septic injury

  2009influential reference
• Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets

  2008cited by this paper
• Reactivation of Cytomegalovirus Infection in Critically Ill Immunocompetent Patients—Reply

  2008cited by this paper
• Cytomegalovirus reactivation in critically ill immunocompetent patients.

  2008cited by this paper
• Regulatory T cell populations in sepsis and trauma

  2008cited by this paper
• IL-7/Anti-IL-7 mAb Complexes Restore T Cell Development and Induce Homeostatic T Cell Expansion without Lymphopenia1

  2008cited by this paper
• Compensatory anti-inflammatory response syndrome

  2008cited by this paper
• Interleukin-7 receptor expression: intelligent design

  2007cited by this paper
• Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation.

  2007cited by this paper
• MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis

  2007cited by this paper
• Pathophysiology of sepsis.

  2007cited by this paper
• Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis.

  2006cited by this paper
• The Role of TCR Engagement and Activation-Induced Cell Death in Sepsis-Induced T Cell Apoptosis1

  2006influential reference
• Surgical critical care: Fungal infections in surgical patients

  2006cited by this paper
• IL-7 Administration to Humans Leads to Expansion of CD8+ and CD4+ Cells but a Relative Decrease of CD4+ T-Regulatory Cells

  2006cited by this paper
• Prolonged Lymphopenia, Lymphoid Depletion, and Hypoprolactinemia in Children with Nosocomial Sepsis and Multiple Organ Failure1

  2005cited by this paper
• The Many Faces of IL-7: From Lymphopoiesis to Peripheral T Cell Maintenance

  2005cited by this paper
• IL-7 and IL-15: therapeutic cytokines for immunodeficiency.

  2005cited by this paper
• Homing and cellular traffic in lymph nodes

  2003cited by this paper
• The pathophysiology and treatment of sepsis.

  2003cited by this paper
• Depletion of Dendritic Cells, But Not Macrophages, in Patients with Sepsis

  2002cited by this paper
• Sepsis-Induced Apoptosis Causes Progressive Profound Depletion of B and CD4+ T Lymphocytes in Humans1

  2001cited by this paper
• Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care

  2001cited by this paper
• Interleukin-7 restores immunity in athymic T-cell-depleted hosts.

  2001cited by this paper
• Normal responses to injury prevent systemic inflammation and can be immunosuppressive.

  2001cited by this paper
• Deaths: final data for 1998.

  2000cited by this paper
• Sepsis after major visceral surgery is associated with sustained and interferon-gamma-resistant defects of monocyte cytokine production.

  2000cited by this paper
• Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo

  2000cited by this paper
• The T cell response against fungal infections.

  1997cited by this paper
• An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis.

  1997cited by this paper
• The Delayed Hypersensitivity Response and Host Resistance in Surgical Patients: 20 Years Later

  1995cited by this paper
• Polymicrobial sepsis but not low-dose endotoxin infusion causes decreased splenocyte IL-2/IFN-gamma release while increasing IL-4/IL-10 production.

  1994cited by this paper
• 20 years later.

  1981cited by this paper

• [Clinical features and early warning of the sepsis in immunocompromised host sepsis].

  2025cites this paper
• Immune Phenotypes in Patients With Invasive Mould Infection Support the Use of PD‐1 Inhibition as Potential Treatment Option

  2025cites this paper
• Analysis of the association of neutrophil-to-lymphocyte ratio, MPV-to-platelet ratio, and clinical risk factors for mortality in ICU patients with candidemia: a 10-year retrospective analysis

  2025cites this paper
• The immunosuppressive mechanisms induced by sepsis and the corresponding treatment strategies

  2025cites this paper
• Antifungal immunity: advances in PRR recognition, adaptive responses, and immune-based therapies

  2025cites this paper
• Inflammatory Response and Anti-Inflammatory Treatment in Persistent Inflammation-Immunosuppression-Catabolism Syndrome (PICS)

  2025cites this paper
• Endogenous IL-7 Variation in Relation to Lymphocyte Subtypes in Septic Patients

  2025cites this paper
• Dose Optimization of rhIL‐7‐hyFc for Patients With Lymphopenia Using a Neonatal Fc Receptor‐Mediated Recycling‐Based and Target‐Mediated Drug Disposition Pharmacokinetic Model

  2025cites this paper
• The immunology of sepsis: translating new insights into clinical practice

  2025cites this paper
• Recombinant interleukin-7 treatment of refractory Mycobacterium avium complex lung disease (IMPULSE-7): a pilot phase II, single-center, randomized, clinical trial

  2025cites this paper
• Dynamic functional assessment of T cells reveals an early suppression correlating with adverse outcome in polytraumatized patients

  2025cites this paper
• Potential of interleukin-7 in sepsis as a biomarker and therapeutic agent: a narrative review

  2025cites this paper
• The effect of adoptive transferring myeloid-derived suppressor cells in ventilator-induced lung injury mice

  2024cites this paper
• Exploring the role of antioxidants in sepsis-associated oxidative stress: a comprehensive review

  2024cites this paper
• Persistent inflammation, immunosuppression, and catabolism syndrome (PICS): a review of definitions, potential therapies, and research priorities

  2024cites this paper
• Adjunctive immunotherapeutic agents in patients with sepsis and septic shock: a multidisciplinary consensus of 23

  2024cites this paper
• Navigating the Modern Landscape of Sepsis: Advances in Diagnosis and Treatment

  2024cites this paper
• Immune dysregulation in sepsis: experiences, lessons and perspectives

  2023cites this paper
• Immune Adjuvant Therapy With Interleukin-7 in a Lymphopenic Patient With Aplastic Anemia and Mucormycosis

  2023cites this paper
• Prognostic Value of Vertebral Bone Density in the CT Scans of Sepsis Patients Admitted to the Intensive Care Unit.

  2023cites this paper
• Interleukin-7 and interleukin-15 as prognostic biomarkers in sepsis and septic shock: Correlation with inflammatory markers and mortality.

  2023cites this paper
• Inefficient Recovery of Repeatedly Stimulated Memory CD8 T Cells after Polymicrobial Sepsis Induction Leads to Changes in Memory CD8 T Cell Pool Composition.

  2023cites this paper
• Sepsis-induced changes in differentiation, maintenance, and function of memory CD8 T cell subsets

  2023cites this paper
• Exploiting antifungal immunity in the clinical context.

  2023cites this paper
• The implication of targeting PD-1:PD-L1 pathway in treating sepsis through immunostimulatory and anti-inflammatory pathways

  2023cites this paper
• Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients

  2022cites this paper
• Osteoporosis is a novel risk factor of infections and sepsis: A cohort study

  2022cites this paper
• MDSCs in sepsis-induced immunosuppression and its potential therapeutic targets.

  2022cites this paper
• Multi-Omics Techniques Make it Possible to Analyze Sepsis-Associated Acute Kidney Injury Comprehensively

  2022cites this paper
• Changes in immune function and immunomodulatory treatments of septic patients.

  2022cites this paper
• SARS-CoV-2 pneumonia and bacterial pneumonia patients differ in a second hit immune response model

  2022cites this paper
• Immune Deregulation in Sepsis and Septic Shock: Reversing Immune Paralysis by Targeting PD-1/PD-L1 Pathway

  2021cites this paper
• Sepsis and Autoimmune Disease: Pathology, Systems Medicine, and Artificial Intelligence

  2021cites this paper
• Immunological Endotyping of Chronic Critical Illness After Severe Sepsis

  2021cites this paper
• Dysregulated Immunity and Immunotherapy after Sepsis

  2021cites this paper
• IL-7 Immunotherapy in a Nonimmunocompromised Patient With Intractable Fungal Wound Sepsis A nonimmunocompromised patient developed life-threatening soft

  2021cites this paper
• T-cells of invasive candidiasis patients show patterns of T-cell-exhaustion suggesting checkpoint blockade as treatment option.

  2021cites this paper
• Diagnosis and Management of Invasive Fungal Wound Infections in Burn Patients

  2021cites this paper
• The Role of B-Cells and Antibodies against Candida Vaccine Antigens in Invasive Candidiasis

  2021cites this paper
• Effects of IL-7 on sepsis: a systematic review

  2021cites this paper
• Erythrocytes as Biomarkers of Virus and Bacteria in View of Metal Ion Homeostasis

  2021cites this paper
• IL-7 Immunotherapy in a Nonimmunocompromised Patient With Intractable Fungal Wound Sepsis

  2021cites this paper
• Immune Modulation in Critically Ill Septic Patients

  2021cites this paper
• Correction of immunosuppression in aged septic rats by human ghrelin and growth hormone through the vagus nerve-dependent inhibition of TGF-β production

  2020cites this paper
• Frontline Science: OX40 agonistic antibody reverses immune suppression and improves survival in sepsis

  2020cites this paper
• Crosstalk between Dendritic Cells and Immune Modulatory Agents against Sepsis

  2020cites this paper
• Role of the adaptive immune response in sepsis

  2020cites this paper
• Polymicrobial sepsis influences CD8 T cell responses and alters host susceptibility to infection and cancer

  2019cites this paper
• Reactivation Viremia in Pediatric Sepsis*

  2019cites this paper
• TCR activation mimics CD127lowPD-1high phenotype and functional alterations of T lymphocytes from septic shock patients

  2019cites this paper
• Immune Modulation in Pediatric Sepsis

  2019cites this paper
• The Overlooked Immune State in Candidemia: A Risk Factor for Mortality

  2019cites this paper
• Differential Protein Expression Profiles of Bronchoalveolar Lavage Fluid Following Lipopolysaccharide-Induced Direct and Indirect Lung Injury in Mice

  2019cites this paper
• Prospective evaluation of lymphocyte subtyping for the diagnosis of invasive candidiasis in non-neutropenic critically ill patients.

  2019cites this paper
• Comparison of the RNA Content of Extracellular Vesicles Derived from Paracoccidioides brasiliensis and Paracoccidioides lutzii

  2019cites this paper
• Sepsis induces long-lasting impairments in CD4+ T-cell responses despite rapid numerical recovery of T-lymphocyte populations

  2019cites this paper
• Is There a Role for Hematopoietic Growth Factors During Sepsis?

  2018cites this paper
• Inhibition of MicroRNA-23b Attenuates Immunosuppression During Late Sepsis Through NIK, TRAF1, and XIAP

  2018cites this paper
• Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial.

  2018cites this paper
• Management of Sepsis-Induced Immunosuppression.

  2018cites this paper
• The perioperative dynamics of IL-7 following robot-assisted and open colorectal surgery

  2018cites this paper
• Low Interleukin-7 Receptor Messenger RNA Expression Is Independently Associated With Day 28 Mortality in Septic Shock Patients*

  2018cites this paper
• Invasive Fungal Disease in Critically Ill Patients at High Risk: Usefulness of Lymphocyte Subtyping

  2018cites this paper
• Epidemiology and Immune Pathogenesis of Viral Sepsis

  2018cites this paper
• Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections

  2018cites this paper
• A novel approach to candidemia? The potential role of checkpoint inhibition.

  2018cites this paper
• Immune therapy in sepsis: Are we ready to try again?

  2018cites this paper
• Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy

  2018cites this paper
• Novel Interventions: What's New and the Future.

  2018cites this paper
• Bacteria‐induced susceptibility to Candida albicans super‐infection in mice via monocyte methyltransferase Setdb2

  2018influential citation
• Advances in the understanding and treatment of sepsis-induced immunosuppression

  2018cites this paper
• Interleukin 7 immunotherapy improves host immunity and survival in a two‐hit model of Pseudomonas aeruginosa pneumonia

  2017cites this paper
• Molecular Targets for Therapy

  2017cites this paper
• Novel Targets for Drug Development

  2017cites this paper
• Potential Immunotherapeutics for Immunosuppression in Sepsis

  2017cites this paper
• Dying to protect: cell death and the control of T‐cell homeostasis

  2017cites this paper
• Apoptosis-induced lymphopenia in sepsis and other severe injuries

  2017cites this paper
• Global analysis of glycoproteins identifies markers of endotoxin tolerant monocytes and GPR84 as a modulator of TNFα expression

  2017cites this paper
• Deciphering the mechanism of Huang‐Lian‐Jie‐Du‐Decoction on the treatment of sepsis by formula decomposition and metabolomics: Enhancement of cholinergic pathways and inhibition of HMGB‐1/TLR4/NF‐&kgr;B signaling

  2017cites this paper
• Future Directions and Molecular Basis of Ventilator Associated Pneumonia

  2017cites this paper
• Cell-Derived Nanoparticles are Endogenous Modulators of Sepsis With Therapeutic Potential

  2017cites this paper
• Immunotherapy for Fungal Infections

  2017cites this paper
• Modulation of Interleukins in Sepsis-Associated Clotting Disorders

  2017cites this paper
• Anti-PD-L1 peptide improves survival in sepsis.

  2017cites this paper
• Pathogenic, immunologic, and clinical aspects of sepsis – update 2016

  2016cites this paper
• Clinical and Experimental Sepsis Impairs CD8 T-Cell-Mediated Immunity.

  2016cites this paper
• Sepsis and septic shock

  2016cites this paper
• Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.

  2016influential citation
• Critical Illness-Induced Immune Suppression: Current State of the Science.

  2016cites this paper
• In Search of a Cure for Sepsis: Taming the Monster in Critical Care Medicine

  2016cites this paper
• Frontline Science: Defects in immune function in patients with sepsis are associated with PD‐1 or PD‐L1 expression and can be restored by antibodies targeting PD‐1 or PD‐L1

  2016cites this paper
• Adaptive immune function in critical illness

  2016cites this paper
• Balance between Hyperinflammation and Immunosuppression in Sepsis

  2016cites this paper
• Altérations des polynucléaires neutrophiles au cours des états septiques sévères

  2016cites this paper
• The Role of Prostaglandin E2 in Critical Illness-Induced Immune Dysfunction

  2016cites this paper
• Anti-Programed Cell Death Ligand 1 Peptide Improves Survival in Sepsis

  2016cites this paper
• Alterations in Antigen-Specific Naive CD4 T Cell Precursors after Sepsis Impairs Their Responsiveness to Pathogen Challenge

  2015influential citation
• Interleukin-7 and Anti–Programmed Cell Death 1 Antibody Have Differing Effects to Reverse Sepsis-Induced Immunosuppression

  2015influential citation
• The future of murine sepsis and trauma research models

  2015influential citation
• Sepsis: a roadmap for future research.

  2015cites this paper